dc.contributor.author | Aykan, Musa B. | |
dc.contributor.author | Ozgurtas, Taner | |
dc.contributor.author | Elasan, Sadi | |
dc.contributor.author | Acar, Ramazan | |
dc.contributor.author | Aydin, Fevzi N. | |
dc.contributor.author | Yesildal, Fatih | |
dc.contributor.author | Erturk, Ismail | |
dc.contributor.author | Saglam, Kenan | |
dc.date.accessioned | 2021-03-06T12:03:21Z | |
dc.date.available | 2021-03-06T12:03:21Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Erturk I., Saglam K., Elasan S., Aykan M. B. , Acar R., Yesildal F., Aydin F. N. , Ozgurtas T., "Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/midrange ejection fraction via VEGF and sVEGFR-1", SAUDI MEDICAL JOURNAL, cilt.39, ss.1028-1034, 2018 | |
dc.identifier.issn | 0379-5284 | |
dc.identifier.other | av_f20b30e5-eeb9-4428-883f-9ecc1dd063ea | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/158791 | |
dc.identifier.uri | https://doi.org/10.15537/smj.2018.10.22946 | |
dc.description.abstract | Objectives: To investigate the clinical significance of VEGF, sVEGFR-1 in heart failure reduced ejection fraction (HFrEF) and heart failure mid-range ejection fraction (HFmrEF) patients. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.title | Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/midrange ejection fraction via VEGF and sVEGFR-1 | |
dc.type | Makale | |
dc.relation.journal | SAUDI MEDICAL JOURNAL | |
dc.contributor.department | Istanbul Goztepe Training and Research Hospital , , | |
dc.identifier.volume | 39 | |
dc.identifier.issue | 10 | |
dc.identifier.startpage | 1028 | |
dc.identifier.endpage | 1034 | |
dc.contributor.firstauthorID | 257197 | |